Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers

Objective: Delayed-release mesalamine 400 mg capsules containing four 100 mg tablets have been developed for children with ulcerative colitis who have difficulty swallowing. Bioavailability of the mesalamine capsules was compared with existing mesalamine tablets in healthy adults, and the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakate, Abhijeet, McNamee, Brian, Burkindine, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636446/
https://www.ncbi.nlm.nih.gov/pubmed/31372067
http://dx.doi.org/10.2147/CPAA.S193191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636446/
https://www.ncbi.nlm.nih.gov/pubmed/31372067
http://dx.doi.org/10.2147/CPAA.S193191

Ejemplares similares